Cargando…

Primary treatment patterns in women recruited to the Australian Ovarian Cancer Study

Detalles Bibliográficos
Autores principales:	Hung, J, Fereday, S, Harnett, P, Giles, D, Gao, B, Traficante, N, Chenevix-Trench, G, Green, A, Webb, P, Bowtell, D, DeFazio, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327031/ http://dx.doi.org/10.1186/1897-4287-10-S2-A80

Ejemplares similares

The Australian Ovarian Cancer Study
por: Traficante, N, et al.
Publicado: (2012)

Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan
por: Chou, Hung-Hsueh, et al.
Publicado: (2022)

Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis
por: Emmanuel, Catherine, et al.
Publicado: (2011)

Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy
por: Chenevix-Trench, Georgia, et al.
Publicado: (2012)

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
por: Gao, Bo, et al.
Publicado: (2014)

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
por: Thompson, ER, et al.
Publicado: (2012)

Benign serous ovarian tumour: a redefining moment?
por: Hunter, Sally, et al.
Publicado: (2012)

The use of the Illumina FFPE Restoration Protocol to obtain suitable quality DNA for SNP-based CGH– a pilot study
por: Hosein, AN, et al.
Publicado: (2012)

A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival
por: Bolton, KL, et al.
Publicado: (2012)

Reclassifying ovarian cancer: origins, subtypes and resistance to therapy
por: Bowtell, DDL
Publicado: (2012)

Searching for BRCA3 by exome sequencing
por: Makunin, I, et al.
Publicado: (2012)

Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
por: Christie, Elizabeth L., et al.
Publicado: (2019)

High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival
por: Baumbusch, Lars O., et al.
Publicado: (2013)

Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis
por: Sawyer, S, et al.
Publicado: (2012)

Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas
por: Arnold, J M, et al.
Publicado: (2001)

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2010)

Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas
por: Arnold, J M, et al.
Publicado: (2001)

The challenges of finding the gene responsible for a rare, autosomal dominant gastric cancer susceptibility syndrome
por: Li, JJ, et al.
Publicado: (2012)

Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer
por: Beesley, Jonathan, et al.
Publicado: (2012)

The experiences of research participants offered genetic test results as a result of taking part in a population based ovarian cancer research study?
por: Young, MA, et al.
Publicado: (2012)

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma
por: Arnold, J M, et al.
Publicado: (2005)

Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study
por: Majidi, Azam, et al.
Publicado: (2023)

Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer
por: Jung, MoonSun, et al.
Publicado: (2018)

Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer
por: Lai, J, et al.
Publicado: (2003)

Validation study of risk prediction models for female relatives of Australian women with breast cancer
por: MacInnis, R, et al.
Publicado: (2012)

Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin
por: Po, Joseph W, et al.
Publicado: (2018)

Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer
por: Nath, Aritro, et al.
Publicado: (2021)

Identification of new breast cancer predisposition genes via whole exome sequencing
por: Southey, MC, et al.
Publicado: (2012)

Immune checkpoint inhibitors in ovarian cancer: where do we go from here?
por: Yoon, Won-Hee, et al.
Publicado: (2023)

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
por: Gao, Bo, et al.
Publicado: (2018)

Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals
por: Jekimovs, C R, et al.
Publicado: (2005)

Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study
por: Goldsbury, David E., et al.
Publicado: (2023)

Planning for ABF as part of reforming the Australian healthcare system
por: Fodero, L, et al.
Publicado: (2011)

Recruitment and feasibility tool
por: van Leeuwen, Jasper, et al.
Publicado: (2015)

Lung recruitment strategies
por: Gancia, Paolo, et al.
Publicado: (2015)

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
por: Köbel, M, et al.
Publicado: (2014)

Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma
por: Pitiyarachchi, Omali, et al.
Publicado: (2023)

Analysis of the TGFβ functional pathway in epithelial ovarian carcinoma
por: Francis-Thickpenny, K M, et al.
Publicado: (2001)

A novel therapeutic approach to cytokine modulation in articular inflammation using filarial nematode derived ES-62
por: McInnes, IB, et al.
Publicado: (2003)

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study
por: Chang, Jiun-Horng, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_up2bgckaephemueuldgqdtoen1